// App-Quantinova.ai

[OP0086] : EULAR RECOMMENDATIONS FOR Women's HEALTH AND THE MANAGEMENT OF FAMILY PLANNING, ASSISTED REPRODUCTION, PREGNANCY, AND MENOPAUSE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND/OR THE ANTIPHOSPHOLIPID SYNDROME

Researchers

Presenter

  • L. Andreoli

Principal Investigators

  • N. Agmon-Levin

  • J. King

  • A. Lojacono

  • F. Marchiori

  • P. Meroni

  • M. Mosca

  • M. Motta

  • M. Ostensen

  • C. Pamfil

  • L. Raio

  • M. Schneider

  • S. Brown

  • E. Svenungsson

  • M. Tektonidou

  • S. Yavuz

  • D. Boumpas

  • A. Tincani

  • R. Cervera

  • N. Costedoat-Chalumeau

  • A. Doria

  • R. Fischer-Betz

  • F. Forger

  • M. Moraes-Fontes

  • M. Khamashta

Medical Centers

  • University, Bari, Italy

  • Chaim Sheba Medical Center, Tel Hashomer, Israel

  • University of Pavia, Pavia, Italy

  • Berne University, Bern, Switzerland.

  • Hospital Clinic Barcelona, Barcelona, Spain

  • Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

  • Athens University, Athens, Greece

  • University, Cluj-Napoca, Romania

  • University of Pavia, Pavia, Italy

  • PatientsRepresentative, London, United Kingdom

  • University Hospital, Duesseldorf, Germany

  • Marmara University, Medical Oncology, Istanbul, Turkey

  • University of Crete, Heraklion, Greece

  • Karolinska University Hospital, Stockholm, Sweden

  • Hospital Curry Cabral, Lisboa, Portugal

  • Hopital Cochin, Paris, France

  • NationalCenterForPregnancy&RheumaticDisease, Trondheim, Norway

Locations

  • Italy

  • Greece

  • Norway

  • Spain

  • Germany

  • United Kingdom

  • Switzerland

  • Turkey

  • Sweden

  • Portugal

  • Israel

  • France

  • Romania

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

  • Antiphospholipid syndrome

  • Placental insufficiency

  • Lupus nephritis

  • Hypertension

  • Nephritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Cyclosporine A

  • Oraprine

  • Cyclosporine eent

  • Tacrolimus

  • Aspirin

  • Albyl-E

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim